147 related articles for article (PubMed ID: 35903011)
1. Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Choi SH; Cesar A; Snow TAC; Saleem N; Arulkumaran N; Singer M
Clin Infect Dis; 2023 Feb; 76(4):683-691. PubMed ID: 35903011
[TBL] [Abstract][Full Text] [Related]
2. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
Choi SH; Cesar A; Snow TAC; Saleem N; Arulkumaran N; Singer M
Int J Antimicrob Agents; 2023 Sep; 62(3):106905. PubMed ID: 37385561
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial therapy for chronic bacterial prostatitis.
Perletti G; Marras E; Wagenlehner FM; Magri V
Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
6. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.
Vardakas KZ; Siempos II; Grammatikos A; Athanassa Z; Korbila IP; Falagas ME
CMAJ; 2008 Dec; 179(12):1269-77. PubMed ID: 19047608
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy for pelvic inflammatory disease.
Savaris RF; Fuhrich DG; Maissiat J; Duarte RV; Ross J
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010285. PubMed ID: 32820536
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy for pelvic inflammatory disease.
Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010285. PubMed ID: 28436019
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for treating scrub typhus.
El Sayed I; Liu Q; Wee I; Hine P
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD002150. PubMed ID: 30246875
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis.
Basilim A; Wali H; Rabaan AA; Eljaaly K
Respir Med Res; 2022 Nov; 82():100931. PubMed ID: 35905552
[TBL] [Abstract][Full Text] [Related]
11. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
Eljaaly K; Alshehri S; Aljabri A; Abraham I; Al Mohajer M; Kalil AC; Nix DE
BMC Infect Dis; 2017 Jun; 17(1):385. PubMed ID: 28576117
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
Vardakas KZ; Trigkidis KK; Falagas ME
Clin Microbiol Infect; 2017 Apr; 23(4):234-241. PubMed ID: 27965070
[TBL] [Abstract][Full Text] [Related]
13. Macrolide antibiotics for bronchiectasis.
Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
[TBL] [Abstract][Full Text] [Related]
14. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.
Jasper AS; Musuuza JS; Tischendorf JS; Stevens VW; Gamage SD; Osman F; Safdar N
Clin Infect Dis; 2021 Jun; 72(11):1979-1989. PubMed ID: 32296816
[TBL] [Abstract][Full Text] [Related]
15. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Ashy N; Alharbi L; Alkhamisi R; Alradadi R; Eljaaly K
J Infect Chemother; 2022 Aug; 28(8):1148-1152. PubMed ID: 35523718
[TBL] [Abstract][Full Text] [Related]
18. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
Lee JH; Kim HJ; Kim YH
J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
[TBL] [Abstract][Full Text] [Related]
19. Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials.
Skalsky K; Yahav D; Lador A; Eliakim-Raz N; Leibovici L; Paul M
Clin Microbiol Infect; 2013 Apr; 19(4):370-8. PubMed ID: 22489673
[TBL] [Abstract][Full Text] [Related]
20. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
